YA II PN, Ltd. - 16 Jun 2025 SCHEDULE 13G Report for Aptevo Therapeutics Inc. Common Stock (APVO)

Filing Manager
YA II PN, Ltd.
Reporting Manager
YA II PN, Ltd.
Symbol
APVO
Shares outstanding
3,582,002 shares
Disclosed Ownership
357,842 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
08 Jul 2025, 14:11:55 UTC
Date of event
16 Jun 2025

Sponsored

Quoteable Key Fact

"YA II PN, Ltd. disclosed 10% ownership in Aptevo Therapeutics Inc. Common Stock (APVO) on 16 Jun 2025."

Quick Takeaways

  • YA II PN, Ltd. filed SCHEDULE 13G for Aptevo Therapeutics Inc. Common Stock (APVO).
  • Disclosed ownership: 10%.
  • Date of event: 16 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 08 Jul 2025, 14:11.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
YA II PN, Ltd. 10% 357,842 0 357,842 /s/ David Gonzalez David Gonzalez, General Counsel
YA Global Investments II (U.S.), LP 10% 357,842 0 357,842 /s/ David Gonzalez David Gonzalez, General Counsel
Yorkville Advisors Global, LP 10% 357,842 0 357,842 /s/ David Gonzalez David Gonzalez, General Counsel
Yorkville Advisors Global II, LLC 10% 357,842 0 357,842 /s/ David Gonzalez David Gonzalez, General Counsel
YAII GP, LP 10% 357,842 0 357,842 /s/ David Gonzalez David Gonzalez, General Counsel
YAII GP II, LLC 10% 357,842 0 357,842 /s/ David Gonzalez David Gonzalez, General Counsel
Mark Angelo 10% 357,842 0 357,842 /s/ Mark Angelo Mark Angelo
SC-Sigma Global Partners, LP 10% 357,842 0 357,842 /s/ David Gonzalez David Gonzalez, General Counsel